Inappropriate use of antiarrhythmic drugs in paroxysmal and persistent atrial fibrillation in a large contemporary international survey: insights from RealiseAF-Reference-Cited by-同舟云学术

Inappropriate use of antiarrhythmic drugs in paroxysmal and persistent atrial fibrillation in a large contemporary international survey: insights from RealiseAF

Published:2013-07-14 Issue:12 Volume:15 Page:1733-1740
ISSN:1099-5129
Container-title:Europace
language:en
Short-container-title:Europace

Author:

Chiang C.-E.,Goethals M.,O'Neill J. O.,Naditch-Brule L.,Brette S.,Gamra H.,Zharinov O.,Steg P. G.,

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/europace/article-pdf/15/12/1733/7278969/eut204.pdf

Reference19 articles.

1. Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association

2. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary

3. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society

4. Atrial fibrillation management: a prospective survey in ESC Member Countries

5. Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of improvement in left ventricular systolic function after catheter ablation in patients with persistent atrial fibrillation complicated with heart failure;BMC Cardiovascular Disorders;2024-03-23

2. Overview of the use of antiarrhythmic drugs at a tertiary hospital in Oman;Pharmacy Practice;2023-06-30

3. Do Elderly Patients with Heart Failure and Reduced Ejection Fraction Benefit from Pharmacological Strategies for Prevention of Arrhythmic Events?;Cardiology;2023

4. Antiarrhythmic drugs for atrial fibrillation: lessons from the past and opportunities for the future;EP Europace;2021-04-01

5. Arrhythmias;Reference Module in Biomedical Sciences;2021